Oxprenolol (versus unexposed)

Exposed non-exposed studies (cohort)

Study Country
Study period
Population source Exposure definition Non-exposure definition Sample size Rmk
Fidler, 1983 United Kingdom (UK)
Not specified.
All the women booked for delivery at Queen Charlotte's Maternity Hospital who had diastolic blood pressure of at least 95mm Hg on two separate occasions at least 24 hours apart or greater than105mm Hg on one occasion. Hypertensive pregnant patients allocated at random to receive oxprenolol (80mg twice a day and increased until 640 mg a day if necessary). unexposed, disease free
Normotensive pregnant women with the nearest hospital reference number after that of the index patient, matched for parity and gestational age at delivery.
50 / 96 Considered as a prospective cohort rather than a randomized control because patients were randomly allocated to methyldopa or oxprenolol but the Normotensive control group not randomly selected.

Case-control studies (cohort)

Study Country
Study period
Case Control Sample size Rmk
Medveczky, 2004 Hungary
1980 - 1996
Newborn infants (including infant deaths and usual stillborn fetuses) with Neural tube defects with non-syndromic (i.e. isolated anencephaly, spina bifida aperta/cystica, encephalocele). Newborn infants (including infant deaths and usual stillborn fetuses) without congenital abnormalities. 1202 / 38151 Study design completed with other studies published on the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA).
Puho, 2007 Hungary
1980–1996
Cases with isolated cleft lip with or without cleft palate (CL/P) and posterior cleft palate (PCP). Newborn infants without congenital abnormalities 1975 / 38151

master protocol